2-keto-4-methylvalerate has been researched along with Alloxan Diabetes in 10 studies
alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stec, DF | 1 |
| Wang, S | 1 |
| Stothers, C | 1 |
| Avance, J | 1 |
| Denson, D | 1 |
| Harris, R | 1 |
| Voziyan, P | 1 |
| Grill, V | 2 |
| Efendić, S | 1 |
| Giroix, MH | 1 |
| Portha, B | 1 |
| Kergoat, M | 1 |
| Bailbe, D | 1 |
| Picon, L | 1 |
| Kilberg, MS | 1 |
| Gwynn, MB | 1 |
| Patston, PA | 1 |
| Espinal, J | 1 |
| Randle, PJ | 1 |
| Hutson, SM | 1 |
| Harper, AE | 1 |
| Sterniczuk, A | 1 |
| Wałajtys-Rode, EI | 1 |
| Wojtczak, AB | 1 |
| Rundfeldt, M | 1 |
| Brosnan, ME | 1 |
| Lowry, A | 1 |
| Brosnan, JT | 1 |
| Aftring, RP | 1 |
| Manos, PN | 1 |
| Buse, MG | 1 |
10 other studies available for 2-keto-4-methylvalerate and Alloxan Diabetes
| Article | Year |
|---|---|
Alterations of urinary metabolite profile in model diabetic nephropathy.
Topics: Aconitic Acid; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitu | 2015 |
Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
Topics: 1-Methyl-3-isobutylxanthine; Alloxan; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experi | 1984 |
Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
Topics: Acetylcholine; Amino Acids; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Gluco | 1983 |
Plasma membrane transport of 2-ketoisocaproate by rat hepatocytes in primary culture.
Topics: Animals; Biological Transport; Cell Membrane; Cells, Cultured; Dexamethasone; Diabetes Mellitus, Exp | 1983 |
Effects of diet and of alloxan-diabetes on the activity of branched-chain 2-oxo acid dehydrogenase complex and of activator protein in rat tissues.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Animals; Cell Fractionation; Diabetes Mellitus, E | 1984 |
Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
Topics: Amino Acids, Branched-Chain; Animals; Diabetes Mellitus, Experimental; Diet; Hemiterpenes; Humans; I | 1981 |
Decarboxylation of branched-chain alpha-ketoacids in hepatocytes from alloxan-diabetic rats. The effect of insulin.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Animals; Decarboxylation; Diabetes Mellitus, Expe | 1991 |
Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Blood Glucose; Dexamethasone; Diabetes Mellitus, Experimental; | 1986 |
Diabetes increases active fraction of branched-chain 2-oxoacid dehydrogenase in rat brain.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Enzyme Activation; Keto Acids; Male; Rats; Rats, In | 1986 |
Catabolism of branched-chain amino acids by diaphragm muscles of fasted and diabetic rats.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Amination; Amino Acids, Branched-Chain; Animals; | 1985 |